17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      On the nature of cancer and why anticancer vaccines don't work

      research-article
      1 ,
      Cancer Cell International
      BioMed Central

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this essay I suggest that the major difficulty in producing effective anti-cancer vaccines lies in the fact that most cancers have little immunogenicity because of a basic paucity of tumor-specific antigenicity. The lack of antigenicity, despite extensive genomic instability, could be explained if most tumor mutations occur in silenced genes. A further problem is that an immune reaction against tumor antigens, especially in moderate or low amount, may be stimulatory rather than inhibitory to tumor growth.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: not found
          • Article: not found

          Immunity to methylcholanthrene-induced sarcomas.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The somatic mutation theory of cancer: growing problems with the paradigm?

            The somatic mutation theory has been the prevailing paradigm in cancer research for the last 50 years. Its premises are: (1) cancer is derived from a single somatic cell that has accumulated multiple DNA mutations, (2) the default state of cell proliferation in metazoa is quiescence, and (3) cancer is a disease of cell proliferation caused by mutations in genes that control proliferation and the cell cycle. From this compelling simplicity, an increasingly complicated picture has emerged as more than 100 oncogenes and 30 tumor suppressor genes have been identified. To accommodate this complexity, additional ad hoc explanations have been postulated. After a critical review of the data gathered from this perspective, an alternative research program has been proposed. It is based on the tissue organization field theory, the premises of which are that carcinogenesis represents a problem of tissue organization, comparable to organogenesis, and that proliferation is the default state of all cells. The merits of these competing theories are evaluated herein.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation.

              A concept of neoplasms, based upon developmental and oncological principles, states that carcinomas are caricatures of tissue renewal, in that they are composed of a mixture of malignant stem cells, which have a marked capacity for proliferation and a limited capacity for differentiation under normal homeostatic conditions, and of the differentiated, possibly benign, progeny of these malignant cells. The concept brings order to the facts about carcinoma, has predictive value for embryogenesis, and indicates possibilities for differentiation therapy. One such possibility assumes on the basis of experimentation in vitro that malignant stem cells can be induced to differentiate into postmitotic cells by application of chemicals. Another suggests study of naturally occurring substances which regulate cell proliferation and differentiation in adult tissues. The other possibility, based upon experiments in vivo and in vitro, indicates that embryonic fields are capable of converting their closely corresponding malignant lineages into apparently normal lineages responsive to homeostatic control. Induced differentiation of embryonal carcinoma has been achieved in vivo with improvement in longevity of the host and in some cases with apparent cure. However, ultimate success of treatment based upon turning malignant cells into benign cells will depend upon the nature of the benign cells. Will they remain benign?
                Bookmark

                Author and article information

                Journal
                Cancer Cell Int
                Cancer Cell International
                BioMed Central (London )
                1475-2867
                2005
                1 August 2005
                : 5
                : 25
                Affiliations
                [1 ]Dept of Pathology, University of Washington, 5433 South Hudson Street, Seattle, WA 98118, USA
                Article
                1475-2867-5-25
                10.1186/1475-2867-5-25
                1185554
                16060965
                66ab493a-3758-4298-a723-f50b4c5711f5
                Copyright © 2005 Prehn; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 7 June 2005
                : 1 August 2005
                Categories
                Hypothesis

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article